# Trade Mark Journal No.2026/006 6 February 2026

## WO0000001898383 (5)

Office of origin: United States of America

Date of International Registration:7 December 2025
Date of designation in the UK: 7 December 2025

International priority date claimed: 2 July 2025 (United States of America) (99264717)

Class 5
  Pharmaceutical preparations for gene therapy for the treatment of neurodegenerative and ocular disorders; pharmaceutical preparations for gene therapy for the treatment of Neuronal Ceroid Lipofuscinosis Type 2; pharmaceutical preparations for gene therapy for the treatment of genetic disorders.

Tern Therapeutics, LLC

Representative: Neha Bhalani Chiesa Shahinian & Giantomasi PC, 11 Times Sq, 34th Floor, New York NY 10036, UNITED STATES OF AMERICA